After the hue and cry last week over accusations of price gouging over EpiPens, the manufacturer Mylan Pharmaceuticals announced that it would begin supplying a generic anti-anaphalaxis medical device that will be half the current $600 price of EpiPens for a two pack. Mylar noted that the EpiPen brand will also be available for those who are weary of taking generics.
Investors rewarded Mylar at this announcement with a 2% increased valuation in stock. But the public will have lingering suspicions that Heather Bresch sought to inject crony capitalism into EpiPen price gouging.
No comments:
Post a Comment